These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51 related articles for article (PubMed ID: 5348408)
1. A new tremorgen: 3,4-dimethylphenethylamine. Schweitzer JW; Friedhoff AJ; Roll FJ Arch Int Pharmacodyn Ther; 1969 Aug; 180(2):385-90. PubMed ID: 5348408 [No Abstract] [Full Text] [Related]
2. A comparison of the effects of some phenethylamines on the release of radioactivity from isolated rat caudate nucleus prelabelled with 3H-dopamine. Kalix P Arzneimittelforschung; 1986 Jul; 36(7):1019-21. PubMed ID: 3768065 [TBL] [Abstract][Full Text] [Related]
3. Mescaline and other o-methylated beta-phenylethylamines: intrastriatal induction of tremor in rats. Little MD; Dill RE Brain Res; 1969 Apr; 13(2):360-6. PubMed ID: 5772426 [No Abstract] [Full Text] [Related]
4. [The role of brain dopamine]. Rybakowski J Psychiatr Pol; 1972; 6(3):341-4. PubMed ID: 4560234 [No Abstract] [Full Text] [Related]
5. The possible significance of cerebral dopamine for neurology and psychiatry. van Praag HM Psychiatr Neurol Neurochir; 1967; 70(5):361-79. PubMed ID: 4862827 [No Abstract] [Full Text] [Related]
6. Experimentally induced parkinsonism. Poirier LJ; Sourkes TL Res Publ Assoc Res Nerv Ment Dis; 1972; 50():416-33. PubMed ID: 4403656 [No Abstract] [Full Text] [Related]
7. Inhibitors of neuronal monoamine uptake. I. Selective inhibition of 5-hydroxytryptamine uptake by alpha-aminoacid amides of phenethylamines. Lindberg UH; Thorberg SO; Renyi AL; Ross SB; Ogren SO Acta Pharm Suec; 1978; 15(2):87-96. PubMed ID: 676761 [No Abstract] [Full Text] [Related]
8. Schizophrenia and pink spot. Stam FC; Heslinga FJ; van Tilburg W Psychiatr Neurol Neurochir; 1969; 72(6):513-24. PubMed ID: 5369242 [No Abstract] [Full Text] [Related]
9. Are there MAO inhibitors specific for dopamine metabolism? Youdim MB; Holzbauer M Adv Biochem Psychopharmacol; 1977; 16():349-58. PubMed ID: 329649 [No Abstract] [Full Text] [Related]
12. Extrapyramidal dopamine regulation by cholecystokinin and its role in Parkinson's disease. Diamond BI; Pasinetti G; Hitri A; Borison RL Adv Neurol; 1984; 40():483-8. PubMed ID: 6695625 [No Abstract] [Full Text] [Related]
13. Effects of p-chloro-beta-phenylethylamine on the uptake and release of putative amine neurotransmitters in rat brain [proceedings]. Baker GB; Bertollini A; del Carmine R; Martin IL; Raiteri M Br J Pharmacol; 1976 Nov; 58(3):420P. PubMed ID: 11022 [No Abstract] [Full Text] [Related]
14. The action of (-) deprenyl on monoamine turnover rate in rat brain. Zsilla G; Knoll J Adv Biochem Psychopharmacol; 1982; 31():211-7. PubMed ID: 6805258 [No Abstract] [Full Text] [Related]
15. [Clinical treatment of lithium induced tremors with a beta receptor antagonist (propranolol)]. Floru L Int Pharmacopsychiatry; 1971; 6(4):197-222. PubMed ID: 4150620 [No Abstract] [Full Text] [Related]
16. Pharmacological studies on 2- and 4-pyridylethylamides of acetyltropic acid (PAT-2 and PAT-4). Widy E Pol J Pharmacol Pharm; 1975; 27(2):139-52. PubMed ID: 168562 [TBL] [Abstract][Full Text] [Related]
17. Some effects of the hallucinogenic drug 2,5-dimethoxy-4-methylamphetamine on the metabolism of biogenic amines in the rat brain. Leonard BE Br J Pharmacol; 1972 May; 45(1):165P-166P. PubMed ID: 5041482 [No Abstract] [Full Text] [Related]
18. Effect of 5-hydroxytryptophan on brain levels of dopamine, norepinephrine, and serotonin in mice. Everett GM Adv Biochem Psychopharmacol; 1974; 10():261-2. PubMed ID: 4546516 [No Abstract] [Full Text] [Related]
20. Proceedings: On the action of oxotremorine on the cholinergic system of rat brain. Pleul O Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R75. PubMed ID: 4276628 [No Abstract] [Full Text] [Related] [Next] [New Search]